Loading...
Loading...
Medical imaging (X-ray, CT, MRI), electronic health records, clinical trials, ECG/EEG, pathology
12,732 datasets
Martin Baxmann's dataset contains 316 questionnaire responses from children aged 8–16 and their parents/guardians regarding removable orthodontic appliances. The data includes patient-reported perceptions of motivation, treatment experience, and self-reported adherence metrics. The study was conducted retrospectively at a private clinic in Germany and was last updated in April 2026.
A pilot study dataset compares 63 patients with alcohol use disorder, split into groups with and without symptomatic COVID-19. The data includes clinical assessments for alcohol use severity and cognition, alongside inflammatory, biochemical, and lipid blood parameters, measured at two time points six months apart. The dataset was authored by Lea Kozina and shared on figshare under a CC-BY-4.0 license.
A retrospective cohort study of 2,008 heart failure patients admitted to a hospital in Zigong City, China, between December 2016 and June 2019. The data was analyzed to examine the association between discharge destination (home vs. healthcare facility) and readmission risk at 28 days, 3 months, and 6 months. The dataset was created by author Xia Yun and shared under a CC-BY-4.0 license.
289 teenage patients referred for hyperandrogenism and/or menstrual disorders between 2019 and 2022 were studied. The research by Karolina Jakubowska-Kowal, published in 2026, found PCOS prevalence ranged from 46% to 59% depending on the diagnostic criteria applied. The dataset includes clinical and hormonal parameters used to compare groups defined by different diagnostic standards.
An observational study from 2019-2022 analyzed 289 adolescent patients referred for hyperandrogenism or menstrual disorders. The dataset, authored by Karolina Jakubowska-Kowal and last updated in 2026, reports PCOS prevalence rates from 46% to 59% depending on the diagnostic criteria applied.
289 adolescent patients with hyperandrogenism or menstrual disorders were studied from 2019 to 2022. The prevalence of polycystic ovary syndrome ranged from 46% to 59% depending on the diagnostic criteria applied. The dataset, authored by Karolina Jakubowska-Kowal and last updated in April 2026, compares clinical and hormonal profiles across diagnostic groups.
Karolina Jakubowska-Kowal's observational study analyzes the prevalence and clinical-hormonal profile of polycystic ovary syndrome (PCOS) among 289 adolescent patients referred for diagnosis due to hyperandrogenism and/or menstrual disorders between 2019 and 2022. The dataset, last updated in 2026, compares outcomes based on the Ibanez, Peña, and Rotterdam diagnostic criteria, reporting prevalence rates from approximately 46% to 59%.
A cross-sectional dataset of 308 patients with type 2 diabetes mellitus hospitalized at Hebei General Hospital, used to investigate the association between remnant cholesterol levels and non-alcoholic fatty liver disease. The dataset includes results from regression, subgroup, and sensitivity analyses, with findings published by Hang Zhao in April 2026. The data is stored in a DOCX file and is 11.7 KB in size.
A retrospective single-center cohort study of 502 adult COVID-19 patients admitted between September 2022 and February 2023. The dataset, authored by Genhua Mu, supports a nomogram for predicting ARDS progression and invasive ventilation need using plasma hyaluronic acid levels and clinical severity scores.
April 2022 to June 2024 trial data for a phase 1b, randomized, double-blind, placebo-controlled study of the anti-CD20 monoclonal antibody B001 in aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder (NMOSD). The dataset includes safety, pharmacokinetic, pharmacodynamic, and preliminary efficacy results from 22 randomized patients across three dose levels. The data sheet was authored by Dongmei Jia and shared under a CC-BY-4.0 license.
A clinical case series of 16 male VEXAS syndrome patients identified from 4512 consecutive patients with hematologic abnormalities at a Chinese academic hospital between June 2023 and July 2024. The data, authored by Xiang Ren and last updated in April 2026, profiles patient demographics, hematological abnormalities, systemic symptoms, organ involvement, bone marrow findings, and UBA1 gene mutation status. The study concludes VEXAS should be considered in patients with cytopenia regardless of systemic symptoms.
16 male VEXAS syndrome patients were identified from a retrospective analysis of 4512 consecutive patients with hematologic abnormalities at a Chinese academic hospital between June 2023 and July 2024. The data, authored by Xiang Ren and last updated in April 2026, profiles patient demographics, UBA1 gene mutations, hematological abnormalities, and multiorgan involvement.
16 male VEXAS syndrome patients were identified from a retrospective analysis of 4512 patients with hematologic abnormalities at a Chinese academic hospital between June 2023 and July 2024. The dataset, authored by Xiang Ren and last updated in April 2026, profiles patient demographics, clinical presentations, bone marrow findings, and UBA1 gene mutation variants.
16 male VEXAS syndrome patients were identified from a retrospective analysis of 4512 patients with hematologic abnormalities at a Chinese academic hospital between June 2023 and July 2024. The dataset, authored by Xiang Ren and last updated in April 2026, profiles patient demographics, clinical presentations, bone marrow findings, and UBA1 gene mutation types.
16 male VEXAS syndrome patients were identified from a retrospective analysis of 4,512 consecutive patients with hematologic abnormalities at a Chinese academic hospital between June 2023 and July 2024. The data, authored by Xiang Ren and published on figshare, includes patient profiles, laboratory findings, UBA1 mutation status, and treatment responses. Canonical UBA1 pathogenic variants were detected in 81.3% of the patients, with p.M41V being the dominant mutation.
A single-center case series of 16 male VEXAS syndrome patients identified from 4512 consecutive patients with hematologic abnormalities at a Chinese academic hospital between June 2023 and July 2024. The dataset, authored by Xiang Ren, profiles clinical presentations, laboratory findings, bone marrow morphology, and UBA1 gene mutation variants. It was last updated on 2026-04 16.
A retrospective cohort study of 712 adult patients with burn sepsis admitted to a regional burn ICU between 2022 and 2025. The dataset contains longitudinal measurements of 17 biomarkers across nutrition, immunity, and inflammation at five time points (days 1, 3, 7, 14, 21). It was authored by Pei Xu and shared under a CC-BY-4.0 license.
A retrospective cohort of 712 adult patients with burn sepsis admitted to a regional ICU between 2022 and 2025. The dataset includes longitudinal measurements of 17 biomarkers across nutrition, immunity, and inflammation at five time points, used to model survival trajectories and identify patient phenotypes. It was created by Pei Xu and last updated in April 2026.
A retrospective case series of six confirmed cystic nephroma (CN) patients from a single institution between 2010 and 2024. The data likely contains demographics, preoperative imaging findings, surgical interventions, and histopathological and immunohistochemistry results. The dataset was authored by Guo run Zi and shared under a CC-BY-4.0 license.
A retrospective analysis of six confirmed cystic nephroma cases treated at a single institution from 2010 to 2024. The dataset includes patient demographics, imaging findings classified by the Bosniak system, surgical approaches, histopathology, and immunohistochemistry results. It was authored by Guo run Zi and shared under a CC-BY-4.0 license on figshare.